organization · Reporting owner
Francisco Partners GP IV, L.P.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | 10% owner | August 24, 2026 | August 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date August 24, 2026 · Filed August 27, 2026
Jointly reported with FRANCISCO PARTNERS IV, L.P., FRANCISCO PARTNERS IV-A, L.P., Francisco Partners GP IV Management Ltd, Francisco Partners Management, LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy Francisco Partners IV, L.P. | 716,801 |
Reported balance
After 2026-08-24 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-08-24 · Sale · Disposed 72,309 · Balance 716,801 F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/24/2026 at prices ranging from $3.425 to $3.5 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: The reported amount has been adjusted by 721 shares to reflect the sale of such shares by Francisco Partners IV-A, L.P. on August 20, 2026, which were inadvertently reported on a Form 4 filed by the reporting persons on August 21, 2026, as being sold by Francisco Partners IV, L.P. F3: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Francisco Partners IV, L.P. | 652,711 |
Reported balance
After 2026-08-25 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2026-08-25 · Sale · Disposed 64,090 · Balance 652,711 F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/25/2026 at prices ranging from $3.415 to $3.48 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Francisco Partners IV, L.P. | 439,310 |
Reported balance
After 2026-08-26 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2026-08-26 · Sale · Disposed 213,401 · Balance 439,310 F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/26/2026 at prices ranging from $3.44 to $3.545 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Francisco Partners IV, L.P. | 0 |
Reported balance
After 2026-08-26 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2026-08-26 · Sale · Disposed 439,310 · Balance 0 F3: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Francisco Partners IV-A, L.P. | 706,649 |
Reported balance
After 2026-08-24 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2026-08-24 · Sale · Disposed 71,285 · Balance 706,649 F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/24/2026 at prices ranging from $3.425 to $3.5 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: The reported amount has been adjusted by 721 shares to reflect the sale of such shares by Francisco Partners IV-A, L.P. on August 20, 2026, which were inadvertently reported on a Form 4 filed by the reporting persons on August 21, 2026, as being sold by Francisco Partners IV, L.P. F3: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Francisco Partners IV-A, L.P. | 643,466 |
Reported balance
After 2026-08-25 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2026-08-25 · Sale · Disposed 63,183 · Balance 643,466 F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/25/2026 at prices ranging from $3.415 to $3.48 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Francisco Partners IV-A, L.P. | 433,088 |
Reported balance
After 2026-08-26 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2026-08-26 · Sale · Disposed 210,378 · Balance 433,088 F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/26/2026 at prices ranging from $3.44 to $3.545 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Francisco Partners IV-A, L.P. | 0 |
Reported balance
After 2026-08-26 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2026-08-26 · Sale · Disposed 433,088 · Balance 0 F3: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/24/2026 at prices ranging from $3.425 to $3.5 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The reported amount has been adjusted by 721 shares to reflect the sale of such shares by Francisco Partners IV-A, L.P. on August 20, 2026, which were inadvertently reported on a Form 4 filed by the reporting persons on August 21, 2026, as being sold by Francisco Partners IV, L.P.
F3: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership.
F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/25/2026 at prices ranging from $3.415 to $3.48 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/26/2026 at prices ranging from $3.44 to $3.545 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONNECTURE INC
Report date April 25, 2018 · Filed April 27, 2018
Jointly reported with Francisco Partners GP IV Management Ltd, FRANCISCO PARTNERS IV-A, L.P., FRANCISCO PARTNERS IV, L.P.
Section 16 reporting ended · disclosed 2018-04-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2018-04-25 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-04-25 · Other · Disposed 3,624,022 · Balance 0 F1: Consists of 2,414,050 shares of common stock, par value $0.001 per share ("Common Stock") of Connecture, Inc. (the "Issuer") directly held by Francisco Partners IV, L.P. ("FP IV") and 1,209,972 shares of Common Stock directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). F2: On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares. F3: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F4: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. |
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnotes | 0 |
Reported balance
After 2018-04-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-04-25 · Other · Disposed 50,000 · Balance 0 F5: The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date. F6: Consists of 33,306 shares of Series A Preferred Stock directly held by FP IV and 16,694 shares of Series A Preferred Stock directly held by FP IV-A. F2: On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares. F3: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F4: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. |
| Series B Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnotes | 0 |
Reported balance
After 2018-04-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-04-25 · Other · Disposed 16,500 · Balance 0 F7: The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date. F8: Consists of 10,991 shares of Series B Preferred Stock directly held by FP IV and 5,509 shares of Series B Preferred Stock directly held by FP IV-A. F2: On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares. F3: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F4: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 2,414,050 shares of common stock, par value $0.001 per share ("Common Stock") of Connecture, Inc. (the "Issuer") directly held by Francisco Partners IV, L.P. ("FP IV") and 1,209,972 shares of Common Stock directly held by Francisco Partners IV-A, L.P. ("FP IV-A").
F2: On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares.
F3: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
F4: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.
F5: The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date.
F6: Consists of 33,306 shares of Series A Preferred Stock directly held by FP IV and 16,694 shares of Series A Preferred Stock directly held by FP IV-A.
F7: The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date.
F8: Consists of 10,991 shares of Series B Preferred Stock directly held by FP IV and 5,509 shares of Series B Preferred Stock directly held by FP IV-A.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2026 Filed Aug 27, 2026 01:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 433,088 | $3.50 | $1,515,808.00 |
DisclosureSEC source: 0001193125-26-369287 · ownership.xml · nonDerivative · entry 8 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 0 F3 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 26, 2026 Filed Aug 27, 2026 01:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 439,310 | $3.50 | $1,537,585.00 |
DisclosureSEC source: 0001193125-26-369287 · ownership.xml · nonDerivative · entry 7 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 0 F3 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 26, 2026 Filed Aug 27, 2026 01:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 210,378 | $3.51 | $738,952.73 |
DisclosureSEC source: 0001193125-26-369287 · ownership.xml · nonDerivative · entry 6 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 433,088 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/26/2026 at prices ranging from $3.44 to $3.545 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 26, 2026 Filed Aug 27, 2026 01:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 213,401 | $3.51 | $749,571.01 |
DisclosureSEC source: 0001193125-26-369287 · ownership.xml · nonDerivative · entry 5 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 439,310 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/26/2026 at prices ranging from $3.44 to $3.545 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 01:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 63,183 | $3.44 | $217,659.12 |
DisclosureSEC source: 0001193125-26-369287 · ownership.xml · nonDerivative · entry 4 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 643,466 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/25/2026 at prices ranging from $3.415 to $3.48 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 01:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 64,090 | $3.44 | $220,783.64 |
DisclosureSEC source: 0001193125-26-369287 · ownership.xml · nonDerivative · entry 3 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 652,711 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/25/2026 at prices ranging from $3.415 to $3.48 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 24, 2026 Filed Aug 27, 2026 01:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 71,285 | $3.46 | $246,788.67 |
DisclosureSEC source: 0001193125-26-369287 · ownership.xml · nonDerivative · entry 2 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 706,649 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/24/2026 at prices ranging from $3.425 to $3.5 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: The reported amount has been adjusted by 721 shares to reflect the sale of such shares by Francisco Partners IV-A, L.P. on August 20, 2026, which were inadvertently reported on a Form 4 filed by the reporting persons on August 21, 2026, as being sold by Francisco Partners IV, L.P. F3 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 24, 2026 Filed Aug 27, 2026 01:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 72,309 | $3.46 | $250,333.76 |
DisclosureSEC source: 0001193125-26-369287 · ownership.xml · nonDerivative · entry 1 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 716,801 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/24/2026 at prices ranging from $3.425 to $3.5 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: The reported amount has been adjusted by 721 shares to reflect the sale of such shares by Francisco Partners IV-A, L.P. on August 20, 2026, which were inadvertently reported on a Form 4 filed by the reporting persons on August 21, 2026, as being sold by Francisco Partners IV, L.P. F3 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 21, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 136,379 | $3.50 | $476,890.09 |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 10 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 777,213 F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/21/2026 at prices ranging from $3.445 to $3.565 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 21, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 138,338 | $3.50 | $483,740.32 |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 9 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 789,831 F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/21/2026 at prices ranging from $3.445 to $3.565 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 20, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 213,844 | $3.52 | $752,837.80 |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 8 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 913,592 F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/20/2026 at prices ranging from $3.465 to $3.59 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 20, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 233,415 | $3.52 | $821,737.51 |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 7 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 928,169 F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/20/2026 at prices ranging from $3.465 to $3.59 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 19, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 2,504,097 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · derivative · entry 12 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 17,554,793 Underlying: Class A Common Stock · 2,504,097 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F1 · price: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F1 · derivative.exercise_date: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F1 · derivative.expiration_date: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 19, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 4,995,903 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · derivative · entry 11 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 35,023,391 Underlying: Class A Common Stock · 4,995,903 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F1 · price: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F1 · derivative.exercise_date: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F1 · derivative.expiration_date: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 19, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 234,304 | $3.53 | $827,069.69 |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 6 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 1,127,436 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/19/2026 at prices ranging from $3.465 to $3.59 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 19, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 237,671 | $3.53 | $838,954.86 |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 5 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 1,161,584 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/19/2026 at prices ranging from $3.465 to $3.59 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 19, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | OtherClass A Common Stock | 1,142,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 4 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 1,361,740 F4 · kind: Francisco Partners IV-A, L.P. made a pro rata distribution of 1,142,357 shares of Class A Shares to its general partner and limited partners for no consideration on August 19, 2026. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 19, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | OtherClass A Common Stock | 3,596,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 3 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 1,399,255 F3 · kind: Francisco Partners IV, L.P. made a pro rata distribution of 3,596,648 shares of Class A Shares to its general partner and limited partners for no consideration on August 19, 2026. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 19, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 2,504,097 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 2 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 2,504,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F1 · price: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| August 19, 2026 Filed Aug 22, 2026 01:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 4,995,903 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-361608 · ownership.xml · nonDerivative · entry 1 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 4,995,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F1 · price: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership. Read SEC document |
| March 16, 2025 Filed Mar 18, 2025 20:18 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 3,338,798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-041214 · ownership.xml · derivative · entry 6 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 20,058,890 Underlying: Class A Common Stock · 3,338,798 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · kind: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · price: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · derivative.exercise_date: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · derivative.expiration_date: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 16, 2025 Filed Mar 18, 2025 20:18 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 6,661,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-041214 · ownership.xml · derivative · entry 5 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 40,019,294 Underlying: Class A Common Stock · 6,661,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · kind: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · price: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · derivative.exercise_date: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · derivative.expiration_date: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 16, 2025 Filed Mar 18, 2025 20:18 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Disposition to issuerClass A Common Stock | 3,338,798 | $4.20 | $14,022,951.60 |
DisclosureSEC source: 0000950170-25-041214 · ownership.xml · nonDerivative · entry 4 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 0 F3 · price: The reported amounts give effect to the closing of the Repurchase, which is expected to occur on March 21, 2025. F3 · balance_after: The reported amounts give effect to the closing of the Repurchase, which is expected to occur on March 21, 2025. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 16, 2025 Filed Mar 18, 2025 20:18 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Disposition to issuerClass A Common Stock | 6,661,202 | $4.20 | $27,977,048.40 |
DisclosureSEC source: 0000950170-25-041214 · ownership.xml · nonDerivative · entry 3 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 0 F3 · price: The reported amounts give effect to the closing of the Repurchase, which is expected to occur on March 21, 2025. F3 · balance_after: The reported amounts give effect to the closing of the Repurchase, which is expected to occur on March 21, 2025. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 16, 2025 Filed Mar 18, 2025 20:18 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 3,338,798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-041214 · ownership.xml · nonDerivative · entry 2 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 3,338,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · price: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 16, 2025 Filed Mar 18, 2025 20:18 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 6,661,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-041214 · ownership.xml · nonDerivative · entry 1 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 6,661,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · price: Pursuant to the Stock Purchase Agreement dated March 16, 2025, the Issuer has agreed to purchase an aggregate of 10,000,000 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $42,000,000 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate of 10,000,000 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 4,882,112 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-028672 · ownership.xml · derivative · entry 6 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 23,397,688 Underlying: Class A Common Stock · 4,882,112 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · kind: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · price: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · derivative.exercise_date: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · derivative.expiration_date: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 9,740,254 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-028672 · ownership.xml · derivative · entry 5 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 46,680,496 Underlying: Class A Common Stock · 9,740,254 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · kind: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · price: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · derivative.exercise_date: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · derivative.expiration_date: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Disposition to issuerClass A Common Stock | 4,882,112 | $7.19 | $35,102,385.28 |
DisclosureSEC source: 0000950170-24-028672 · ownership.xml · nonDerivative · entry 4 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 0 F3 · shares: The reported amounts give effect to the closing of the Repurchase, which is expected to occur on March 11, 2024. F3 · balance_after: The reported amounts give effect to the closing of the Repurchase, which is expected to occur on March 11, 2024. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Disposition to issuerClass A Common Stock | 9,740,254 | $7.19 | $70,032,426.26 |
DisclosureSEC source: 0000950170-24-028672 · ownership.xml · nonDerivative · entry 3 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 0 F3 · shares: The reported amounts give effect to the closing of the Repurchase, which is expected to occur on March 11, 2024. F3 · balance_after: The reported amounts give effect to the closing of the Repurchase, which is expected to occur on March 11, 2024. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 4,882,112 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-028672 · ownership.xml · nonDerivative · entry 2 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV-A, L.P. Disclosed balance after: 4,882,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · price: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 9,740,254 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-028672 · ownership.xml · nonDerivative · entry 1 FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners Management, LP · CIK 0001197853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Francisco Partners IV, L.P. Disclosed balance after: 9,740,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F1 · price: Pursuant to the Stock Purchase Agreement dated March 6, 2024, the Issuer has agreed to purchase an aggregate 14,622,366 shares of Class A Common Stock ("Class A Shares") from Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, the "Selling Stockholders") for an aggregate price of $105,134,811.54 (the "Repurchase"). In connection with the Repurchase, the Selling Stockholders are converting an aggregate 14,622,366 shares of Class B Common Stock ("Class B Shares") into Class A Shares on a one-for-one basis. F2 · ownership.nature: Francisco Partners GP IV, L.P. ("Francisco Partners GP IV") is the general partner of each of Francisco Partners IV, L.P. ("Francisco Partners IV") and Francisco Partners IV-A, L.P. ("Francisco Partners IV-A"). Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV. Francisco Partners Management, L.P. ("Francisco Partners Management") serves as the investment manager for each of Francisco Partners IV and Francisco Partners IV-A. Voting and disposition decisions at Francisco Partners Management with respect to the shares of Class B common stock held by Francisco Partners IV and Francisco Partners IV-A are made by an investment committee. Each of Francisco Partners Management, Francisco Partners GP IV Management Limited and Francisco Partners GP IV may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership except to the extent of their pecuniary interest. Read SEC document |
| April 25, 2018 Filed Apr 27, 2018 21:11 UTC | CONNECTURE INC CNXR · Entity 167208 | OtherSeries B Convertible Preferred Stock · Derivative | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-010894 · doc4.xml · derivative · entry 3 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Stock · 10,199,839 shares Expires not disclosed F7 · derivative.exercise_price: The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date. F8 · shares: Consists of 10,991 shares of Series B Preferred Stock directly held by FP IV and 5,509 shares of Series B Preferred Stock directly held by FP IV-A. F2 · price: On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares. F7 · derivative.exercise_date: The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date. F7 · derivative.expiration_date: The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date. F7 · derivative.underlying_shares: The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date. F2 · balance_after: On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares. F3 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F4 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| April 25, 2018 Filed Apr 27, 2018 21:11 UTC | CONNECTURE INC CNXR · Entity 167208 | OtherSeries A Convertible Preferred Stock · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-010894 · doc4.xml · derivative · entry 2 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Stock · 14,629,115 shares Expires not disclosed F5 · derivative.exercise_price: The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date. F6 · shares: Consists of 33,306 shares of Series A Preferred Stock directly held by FP IV and 16,694 shares of Series A Preferred Stock directly held by FP IV-A. F2 · price: On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares. F5 · derivative.exercise_date: The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date. F5 · derivative.expiration_date: The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date. F5 · derivative.underlying_shares: The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date. F2 · balance_after: On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares. F3 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F4 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| April 25, 2018 Filed Apr 27, 2018 21:11 UTC | CONNECTURE INC CNXR · Entity 167208 | OtherCommon Stock | 3,624,022 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-010894 · doc4.xml · nonDerivative · entry 1 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · shares: Consists of 2,414,050 shares of common stock, par value $0.001 per share ("Common Stock") of Connecture, Inc. (the "Issuer") directly held by Francisco Partners IV, L.P. ("FP IV") and 1,209,972 shares of Common Stock directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). F2 · price: On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares. F3 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F4 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| March 10, 2017 Filed Mar 15, 2017 01:00 UTC | CONNECTURE INC CNXR · Entity 167208 | PurchasePreferred Stock Series B Convertible · Derivative | 5,509 | $1,000.00 | $5,509,000.00 |
DisclosureSEC source: 0000899243-17-007521 · doc4.xml · derivative · entry 2 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,509 Underlying: Common Stock · 2,884,293 shares Expires not disclosed F1 · derivative.exercise_price: The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock"), is equal to approximately 523.56 shares, subject to customary adjustments. The Series B Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Series B Preferred Stock into Common Stock after March 10, 2019, if certain conditions are met. F3 · shares: These securities are directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). F1 · derivative.exercise_date: The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock"), is equal to approximately 523.56 shares, subject to customary adjustments. The Series B Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Series B Preferred Stock into Common Stock after March 10, 2019, if certain conditions are met. F1 · derivative.expiration_date: The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock"), is equal to approximately 523.56 shares, subject to customary adjustments. The Series B Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Series B Preferred Stock into Common Stock after March 10, 2019, if certain conditions are met. F1 · derivative.underlying_shares: The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock"), is equal to approximately 523.56 shares, subject to customary adjustments. The Series B Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Series B Preferred Stock into Common Stock after March 10, 2019, if certain conditions are met. F3 · derivative.underlying_shares: These securities are directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). F3 · balance_after: These securities are directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). F3 · ownership.nature: These securities are directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). F4 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). F5 · ownership.nature: The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). F6 · ownership.nature: Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F7 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| March 10, 2017 Filed Mar 15, 2017 01:00 UTC | CONNECTURE INC CNXR · Entity 167208 | PurchasePreferred Stock Series B Convertible · Derivative | 10,991 | $1,000.00 | $10,991,000.00 |
DisclosureSEC source: 0000899243-17-007521 · doc4.xml · derivative · entry 1 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 10,991 Underlying: Common Stock · 5,754,450 shares Expires not disclosed F1 · derivative.exercise_price: The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock"), is equal to approximately 523.56 shares, subject to customary adjustments. The Series B Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Series B Preferred Stock into Common Stock after March 10, 2019, if certain conditions are met. F2 · shares: These securities are directly held by Francisco Partners IV, L.P. ("FP IV"). F1 · derivative.exercise_date: The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock"), is equal to approximately 523.56 shares, subject to customary adjustments. The Series B Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Series B Preferred Stock into Common Stock after March 10, 2019, if certain conditions are met. F1 · derivative.expiration_date: The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock"), is equal to approximately 523.56 shares, subject to customary adjustments. The Series B Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Series B Preferred Stock into Common Stock after March 10, 2019, if certain conditions are met. F1 · derivative.underlying_shares: The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock"), is equal to approximately 523.56 shares, subject to customary adjustments. The Series B Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Series B Preferred Stock into Common Stock after March 10, 2019, if certain conditions are met. F2 · derivative.underlying_shares: These securities are directly held by Francisco Partners IV, L.P. ("FP IV"). F2 · balance_after: These securities are directly held by Francisco Partners IV, L.P. ("FP IV"). F2 · ownership.nature: These securities are directly held by Francisco Partners IV, L.P. ("FP IV"). F4 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). F5 · ownership.nature: The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). F6 · ownership.nature: Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F7 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:26 UTC | CONNECTURE INC CNXR · Entity 167208 | PurchaseCommon Stock | 6,133 | $1.69 | $10,370.90 |
DisclosureSEC source: 0000899243-16-028915 · doc4.xml · nonDerivative · entry 6 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,209,972 F8 · price: The prices reported in Column 4 are weighted average prices. These shares were acquired in multiple transactions at prices ranging from $1.65 to $1.70, inclusive. The Reporting Persons undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.nature: These securities are directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). As of the date of this filing, FP IV-A holds 1,209,972 shares of Common Stock and 16,694 shares of Preferred Stock, which is convertible into 3,755,408 shares of Common Stock. F4 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). F5 · ownership.nature: The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). F6 · ownership.nature: Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F7 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:26 UTC | CONNECTURE INC CNXR · Entity 167208 | PurchaseCommon Stock | 12,237 | $1.69 | $20,692.77 |
DisclosureSEC source: 0000899243-16-028915 · doc4.xml · nonDerivative · entry 5 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,414,050 F8 · price: The prices reported in Column 4 are weighted average prices. These shares were acquired in multiple transactions at prices ranging from $1.65 to $1.70, inclusive. The Reporting Persons undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: These securities are directly held by Francisco Partners IV, L.P. ("FP IV"). The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series A Convertible Preferred Stock, par value $0.001 per share (the "Preferred Stock"), is equal to approximately 224.9556 shares, subject to customary anti-dilution adjustments, paid-in-kind dividends through June 30, 2016 and other adjustments. The Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Preferred Stock into Common Stock after May 2, 2018, if certain conditions are met. As of the date of this filing, FP IV holds 2,414,050 shares of Common Stock and 33,306 shares of Preferred Stock, which is convertible into 7,492,369 shares of Common Stock. F4 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). F5 · ownership.nature: The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). F6 · ownership.nature: Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F7 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 23:26 UTC | CONNECTURE INC CNXR · Entity 167208 | PurchaseCommon Stock | 200 | $1.65 | $330.00 |
DisclosureSEC source: 0000899243-16-028915 · doc4.xml · nonDerivative · entry 4 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,203,839 F3 · ownership.nature: These securities are directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). As of the date of this filing, FP IV-A holds 1,209,972 shares of Common Stock and 16,694 shares of Preferred Stock, which is convertible into 3,755,408 shares of Common Stock. F4 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). F5 · ownership.nature: The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). F6 · ownership.nature: Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F7 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 23:26 UTC | CONNECTURE INC CNXR · Entity 167208 | PurchaseCommon Stock | 400 | $1.65 | $660.00 |
DisclosureSEC source: 0000899243-16-028915 · doc4.xml · nonDerivative · entry 3 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,401,813 F2 · ownership.nature: These securities are directly held by Francisco Partners IV, L.P. ("FP IV"). The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series A Convertible Preferred Stock, par value $0.001 per share (the "Preferred Stock"), is equal to approximately 224.9556 shares, subject to customary anti-dilution adjustments, paid-in-kind dividends through June 30, 2016 and other adjustments. The Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Preferred Stock into Common Stock after May 2, 2018, if certain conditions are met. As of the date of this filing, FP IV holds 2,414,050 shares of Common Stock and 33,306 shares of Preferred Stock, which is convertible into 7,492,369 shares of Common Stock. F4 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). F5 · ownership.nature: The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). F6 · ownership.nature: Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F7 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 23:26 UTC | CONNECTURE INC CNXR · Entity 167208 | PurchaseCommon Stock | 17,753 | $1.63 | $28,951.59 |
DisclosureSEC source: 0000899243-16-028915 · doc4.xml · nonDerivative · entry 2 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,203,639 F1 · price: The prices reported in Column 4 are weighted average prices. These shares were acquired in multiple transactions at prices ranging from $1.63 to $1.65, inclusive. The Reporting Persons undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.nature: These securities are directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). As of the date of this filing, FP IV-A holds 1,209,972 shares of Common Stock and 16,694 shares of Preferred Stock, which is convertible into 3,755,408 shares of Common Stock. F4 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). F5 · ownership.nature: The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). F6 · ownership.nature: Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F7 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 23:26 UTC | CONNECTURE INC CNXR · Entity 167208 | PurchaseCommon Stock | 35,420 | $1.63 | $57,762.94 |
DisclosureSEC source: 0000899243-16-028915 · doc4.xml · nonDerivative · entry 1 Francisco Partners GP IV Management Ltd · CIK 0001673966 · 10% owner Francisco Partners GP IV, L.P. · CIK 0001674067 · 10% owner FRANCISCO PARTNERS IV-A, L.P. · CIK 0001622908 · 10% owner FRANCISCO PARTNERS IV, L.P. · CIK 0001622902 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,401,413 F1 · price: The prices reported in Column 4 are weighted average prices. These shares were acquired in multiple transactions at prices ranging from $1.63 to $1.65, inclusive. The Reporting Persons undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: These securities are directly held by Francisco Partners IV, L.P. ("FP IV"). The number of shares of common stock of Connecture, Inc. (the "Issuer"), having par value of $0.001 per share (the "Common Stock"), deliverable upon conversion of each share of Series A Convertible Preferred Stock, par value $0.001 per share (the "Preferred Stock"), is equal to approximately 224.9556 shares, subject to customary anti-dilution adjustments, paid-in-kind dividends through June 30, 2016 and other adjustments. The Preferred Stock is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Preferred Stock into Common Stock after May 2, 2018, if certain conditions are met. As of the date of this filing, FP IV holds 2,414,050 shares of Common Stock and 33,306 shares of Preferred Stock, which is convertible into 7,492,369 shares of Common Stock. F4 · ownership.nature: The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). F5 · ownership.nature: The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin (collectively, the "FP Directors"). F6 · ownership.nature: Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. F7 · ownership.nature: Each of such Francisco Partners entities and the FP Directors may be deemed to beneficially own the securities of the Issuer beneficially owned by FP IV and FP IV-A directly or indirectly controlled by it, but each (other than FP IV and FP IV-A to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.